193 related articles for article (PubMed ID: 14724149)
1. Chemoprevention of gastric cancer by celecoxib in rats.
Hu PJ; Yu J; Zeng ZR; Leung WK; Lin HL; Tang BD; Bai AH; Sung JJ
Gut; 2004 Feb; 53(2):195-200. PubMed ID: 14724149
[TBL] [Abstract][Full Text] [Related]
2. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
3. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention.
Yu J; Tang BD; Leung WK; To KF; Bai AH; Zeng ZR; Ma PK; Go MY; Hu PJ; Sung JJ
World J Gastroenterol; 2005 Jan; 11(1):41-5. PubMed ID: 15609394
[TBL] [Abstract][Full Text] [Related]
4. Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.
Kuo CH; Hu HM; Tsai PY; Wu IC; Yang SF; Chang LL; Wang JY; Jan CM; Wang WM; Wu DC
World J Gastroenterol; 2009 Oct; 15(39):4907-14. PubMed ID: 19842220
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effects of rofecoxib and folic acid on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.
Fei SJ; Xiao SD; Peng YS; Chen XY; Shi Y
Chin J Dig Dis; 2006; 7(3):134-40. PubMed ID: 16808793
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils.
Futagami S; Kawagoe T; Horie A; Shindo T; Hamamoto T; Suzuki K; Kusunoki M; Miyake K; Gudis K; Tsukui T; Crowe SE; Sakamoto C
Digestion; 2008; 78(2-3):93-102. PubMed ID: 18987470
[TBL] [Abstract][Full Text] [Related]
11. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
Bresalier RS
Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
[No Abstract] [Full Text] [Related]
12. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
13. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
14. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Wilgus TA; Ross MS; Parrett ML; Oberyszyn TM
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):367-84. PubMed ID: 11060900
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
16. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
Okayama M; Hayashi S; Aoi Y; Nishio H; Kato S; Takeuchi K
Dig Dis Sci; 2007 Sep; 52(9):2095-103. PubMed ID: 17429720
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Sakai M; Tanebe K; Sasaki Y; Momma K; Yoneda S; Saito S
Mol Hum Reprod; 2001 Jun; 7(6):595-602. PubMed ID: 11385116
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention by celecoxib in reflux-induced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy.
Rocha FT; Lourenço LG; Jucá MJ; Costa V; Leal AT
Acta Cir Bras; 2009; 24(3):189-94. PubMed ID: 19504000
[TBL] [Abstract][Full Text] [Related]
19. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
20. Effect of S-allylcysteine on oxidant-antioxidant status during N-methyl-N'-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats.
Velmurugan B; Bhuvaneswari V; Nagini S
Asia Pac J Clin Nutr; 2003; 12(4):488-94. PubMed ID: 14672876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]